PROTHENA CORP PUBLIC LTD CO (PRTA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 80M 160M 240M Q3 '16: 1.2M Q4 '16: 1.1M Q1 '17: 1M Q2 '17: 27.5M Q3 '17: 27.5M Q4 '17: 27.5M Q1 '18: 27.5M Q2 '18: 954K Q3 '18: 990K Q4 '18: 955K Q1 '19: 914K Q2 '19: 802K Q3 '19: 752K Q4 '19: 814K Q1 '20: 769K Q2 '20: 797K Q3 '20: 749K Q4 '20: 853K Q1 '21: 872K Q2 '21: 60.7M Q3 '21: 199.8M Q4 '21: 200.6M Q1 '22: 201.6M Q2 '22: 142.8M Q3 '22: 5.2M Q4 '22: 53.9M Q1 '23: 54.9M Q2 '23: 57.6M Q3 '23: 141M Q4 '23: 91.4M Q1 '24: 89.3M Q2 '24: 217.2M Q3 '24: 133.3M Q4 '24: 135.2M Q1 '25: 137.9M Q2 '25: 10.3M Q3 '25: 11.8M Q4 '25: 9.7M Q1 '26: 57.9M Q2 '26: 54.5M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

-300M -200M -100M 0 100M 200M 300M Q3 '16: -134.5M Q4 '16: -159.5M Q1 '17: -168.4M Q2 '17: -146.4M Q3 '17: -157.2M Q4 '17: -155.3M Q1 '18: -167.7M Q2 '18: -212.6M Q3 '18: -183.4M Q4 '18: -158.9M Q1 '19: -133.1M Q2 '19: -88.5M Q3 '19: -85.2M Q4 '19: -85.7M Q1 '20: -87.6M Q2 '20: -95.8M Q3 '20: -105.7M Q4 '20: -112.7M Q1 '21: -120M Q2 '21: -65.3M Q3 '21: 74.8M Q4 '21: 72M Q1 '22: 66.1M Q2 '22: -5M Q3 '22: -164.6M Q4 '22: -131.6M Q1 '23: -149.9M Q2 '23: -173.2M Q3 '23: -112.6M Q4 '23: -191M Q1 '24: -216.2M Q2 '24: -91.4M Q3 '24: -168.2M Q4 '24: -154.6M Q1 '25: -138.6M Q2 '25: -281.6M Q3 '25: -255.3M Q4 '25: -214.6M Q1 '26: -119M Q2 '26: -55.5M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

-450M -300M -150M 0 150M 300M 450M Q3 '16: -135.4M Q4 '16: -160.1M Q1 '17: -168M Q2 '17: -145.2M Q3 '17: -154.4M Q4 '17: -153.2M Q1 '18: -166.6M Q2 '18: -208.8M Q3 '18: -180.9M Q4 '18: -155.6M Q1 '19: -127.8M Q2 '19: -83.7M Q3 '19: -78.6M Q4 '19: -77.7M Q1 '20: -80.4M Q2 '20: -90.9M Q3 '20: -102M Q4 '20: -111.1M Q1 '21: -124.3M Q2 '21: -70.4M Q3 '21: 69.4M Q4 '21: 67M Q1 '22: 67.4M Q2 '22: -1.5M Q3 '22: -156.5M Q4 '22: -116.9M Q1 '23: -127.5M Q2 '23: -140.9M Q3 '23: -73.2M Q4 '23: -147M Q1 '24: -172.4M Q2 '24: -50.9M Q3 '24: -131.8M Q4 '24: -122.3M Q1 '25: -110.3M Q2 '25: -302.9M Q3 '25: -280.5M Q4 '25: -244.1M Q1 '26: -151.2M Q2 '26: -44M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-210M -140M -70M 0 70M 140M 210M Q3 '16: -98.3M Q4 '16: -116.2M Q1 '17: -129M Q2 '17: -137.8M Q3 '17: -125.5M Q4 '17: -131.2M Q1 '18: -124.9M Q2 '18: -30.7M Q3 '18: -46.5M Q4 '18: -28.3M Q1 '19: -14.1M Q2 '19: -84.4M Q3 '19: -59.7M Q4 '19: -53M Q1 '20: -58.7M Q2 '20: -65.3M Q3 '20: -75.8M Q4 '20: -80.4M Q1 '21: -90.9M Q2 '21: -35.5M Q3 '21: 96M Q4 '21: 92.6M Q1 '22: 88.9M Q2 '22: 17M Q3 '22: -126.3M Q4 '22: -108.8M Q1 '23: -118.9M Q2 '23: -128.5M Q3 '23: -87.8M Q4 '23: -133.9M Q1 '24: -159.5M Q2 '24: -98.6M Q3 '24: -153.3M Q4 '24: -150.1M Q1 '25: -130.4M Q2 '25: -192.7M Q3 '25: -188M Q4 '25: -163.6M Q1 '26: -81.3M Q2 '26: -60M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '13: 17.7M Q2 '13: 17.7M Q3 '13: 17.7M Q1 '14: 22.9M Q2 '14: 22.9M Q3 '14: 27.4M Q1 '15: 27.4M Q2 '15: 30.8M Q3 '15: 31.4M Q2 '20: 39.9M Q3 '20: 39.9M Q1 '21: 40.2M Q2 '21: 47.4M Q3 '21: 51.2M Q1 '22: 46.7M Q2 '22: 46.8M Q3 '22: 47M Q1 '23: 52.5M Q2 '23: 53.1M Q3 '23: 58M Q1 '24: 53.7M Q2 '24: 55M Q3 '24: 53.8M Q1 '25: 53.8M Q2 '25: 53.8M Q3 '25: 53.8M Q1 '26: 54.1M Q2 '26: 52.1M Q1 '14 Q2 '15 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -4.00 -2.00 0.00 2.00 4.00 6.00 Q3 '16: -4.01 Q4 '16: -4.66 Q1 '17: -4.84 Q2 '17: -4.12 Q3 '17: -4.23 Q4 '17: -4.06 Q1 '18: -4.33 Q2 '18: -5.37 Q3 '18: -4.62 Q4 '18: -3.94 Q1 '19: -3.20 Q2 '19: -2.10 Q3 '19: -1.97 Q4 '19: -1.95 Q1 '20: -2.02 Q2 '20: -2.28 Q3 '20: -2.56 Q4 '20: -2.79 Q1 '21: -3.11 Q2 '21: -1.87 Q3 '21: 1.03 Q4 '21: 1.38 Q1 '22: 1.51 Q2 '22: 0.05 Q3 '22: -3.05 Q4 '22: -2.47 Q1 '23: -2.58 Q2 '23: -2.73 Q3 '23: -1.38 Q4 '23: -2.80 Q1 '24: -3.25 Q2 '24: -1.00 Q3 '24: -2.48 Q4 '24: -2.29 Q1 '25: -2.07 Q2 '25: -5.63 Q3 '25: -5.21 Q4 '25: -4.54 Q1 '26: -2.82 Q2 '26: -0.84 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.